Introducing FibroScan®: Advanced, Non-Invasive Liver Health Assessment
Alpharetta & Cumming Internal Medicine is proud to offer FibroScan®, a cutting-edge diagnostic tool developed by Echosens, designed to provide quick, painless, and highly accurate assessments of liver health. This innovative technology is transforming the way clinicians evaluate liver conditions, offering a non-invasive alternative to traditional liver biopsies.

What is FibroScan®?
FibroScan® is a non-invasive device that measures two critical indicators of liver health:

Liver Stiffness Measurement (LSM): Assesses the degree of liver fibrosis or scarring.

Controlled Attenuation Parameter (CAP™): Quantifies liver fat content, aiding in the diagnosis of conditions like Non-Alcoholic Fatty Liver Disease (NAFLD).

Using Vibration Controlled Transient Elastography (VCTE™), FibroScan® sends a painless pulse of energy through the liver tissue, allowing clinicians to evaluate liver stiffness. The CAP™ feature simultaneously measures the degree of liver steatosis, providing a comprehensive picture of liver health.

Why Choose FibroScan®?
Non-Invasive & Painless: No needles or sedation required.

Quick Procedure: Typically completed in under 10 minutes.

Immediate Results: Allows for timely clinical decision-making.

Clinically Validated: Supported by over 5,000 peer-reviewed publications and recognized in more than 200 international clinical guidelines .

Who Can Benefit?
FibroScan® is especially beneficial for individuals at risk of liver disease, including those with:

Diabetes
Obesity
High cholesterol
Echosens
History of alcohol use
Digestive and Liver Health Specialists
Liver Health Scan

Early detection through FibroScan® enables timely intervention and personalized patient care, potentially preventing the progression of liver disease.

Take a proactive step towards maintaining your liver health. Contact Alpharetta & Cumming Internal Medicine to schedule your FibroScan® assessment.